These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11964019)

  • 1. Consequences of not treating children with laron syndrome (primary growth hormone insensitivity).
    Laron Z
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1243-8; discussion 1261-2. PubMed ID: 11964019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function.
    Scheinowitz M; Feinberg MS; Laron Z
    Growth Horm IGF Res; 2009 Jun; 19(3):280-2. PubMed ID: 19117781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
    Laron Z
    Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and biological function of the female gonads and genitalia in IGF-I deficiency -- Laron syndrome as a model.
    Laron Z
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():188-91. PubMed ID: 16641857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of the classical form of primary growth hormone (GH) resistance (Laron syndrome).
    Laron Z
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():231-49. PubMed ID: 10698588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormones and osteoporosis update. Growth hormone and bone].
    Tanaka H
    Clin Calcium; 2009 Jul; 19(7):984-9. PubMed ID: 19567995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laron syndrome (primary growth hormone insensitivity): a unique model to explore the effect of insulin-like growth factor 1 deficiency on human hair.
    Lurie R; Ben-Amitai D; Laron Z
    Dermatology; 2004; 208(4):314-8. PubMed ID: 15178913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome.
    Laron Z
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4397-404. PubMed ID: 10599694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term IGF-I treatment of children with Laron syndrome increases adiposity.
    Laron Z; Ginsberg S; Lilos P; Arbiv M; Vaisman N
    Growth Horm IGF Res; 2006 Feb; 16(1):61-4. PubMed ID: 16442822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partial growth hormone insensitivity.
    Johnston LB; Savage MO
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():251-7. PubMed ID: 10698589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-I treatment of growth disorders, diabetes mellitus and insulin resistance.
    Ranke MB
    Trends Endocrinol Metab; 2005; 16(4):190-7. PubMed ID: 15860416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).
    Ranke MB; Wollmann HA; Savage MO
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():259-66. PubMed ID: 10698590
    [No Abstract]   [Full Text] [Related]  

  • 13. Growth hormone-resistant syndromes: long-term follow-up.
    Chernausek SD
    Endocr Dev; 2009; 14():135-42. PubMed ID: 19293580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral and dental findings in a child with growth hormone insensitivity syndrome.
    Abanto J; Celiberti P; Alves FB; Rossier V; Vieira SA; Ciamponi AL; Raggio DP
    J Dent Child (Chic); 2010; 77(1):54-8. PubMed ID: 20359431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne.
    Ben-Amitai D; Laron Z
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):950-4. PubMed ID: 21054577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-1 and insulin as growth hormones.
    Laron Z
    Novartis Found Symp; 2004; 262():56-77; discussion 77-83, 265-8. PubMed ID: 15562823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle force and endurance in untreated and human growth hormone or insulin-like growth factor-I-treated patients with growth hormone deficiency or Laron syndrome.
    Brat O; Ziv I; Klinger B; Avraham M; Laron Z
    Horm Res; 1997; 47(2):45-8. PubMed ID: 9030966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor.
    Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ;
    Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulinlike growth factor I affects ocular development: a study of untreated and treated patients with Laron syndrome.
    Bourla DH; Laron Z; Snir M; Lilos P; Weinberger D; Axer-Siegel R
    Ophthalmology; 2006 Jul; 113(7):1197.e1-5. PubMed ID: 16815402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.